Research Article
Effects of Different Therapeutic Schedules on Patients with COVID-19: A Prospective Case–Control Study in China
Table 2
Laboratory test results of SARS-CoV-2 patients.
| Variables | Total patients () | WM treatment group () | TCM-WM treatment group () | |
| Blood routine | | | | | White blood cell count (×109/L) | 4.9 (4.0-6.7) | 5.0 (4.1-6.4) | 4.9 (4.0-6.3) | 0.412 | Neutrophil count (×109/L) | 3.0 (2.3-3.8) | 3.1 (2.5-3.9) | 3.0 (2.3-4.1) | 0.512 | Lymphocyte count (×109/L) 109/L) | 1.2 (0.8-1.7) | 1.3 (0.9-1.9) | 1.2 (0.8-1.8) | 0.406 | Monocyte count (×109/L) | 0.5 (0.3-0.7) | 0.5 (0.3-0.8) | 0.4 (0.3-0.5) | 0.296 | Platelet count (×109/L) | | | | 0.421 | Hemoglobin (g/L) | | | | 0.362 | Blood biochemistry | | | | | Alanine aminotransferase (U/L) | 21 (14-36) | 21 (15-39) | 20 (11-34) | 0.698 | Albumin (g/L) | 41.5 (38.3-44.7) | 42.1 (39.1-45.2) | 40.2 (38.1-42.8) | 0.137 | Blood urea nitrogen (mmol/L) | 4.2 (3.0-5.2) | 4.2 (3.2-5.2) | 4.3 (2.8-5.0) | 0.286 | Serum creatinine (μmol/L) | 59.7 (49.5-74.2) | 58.6 (48.8-72.0) | 61.0 (51.0-72.0) | 0.136 | Lactate dehydrogenase (U/L) | 191 (155-278) | 182 (149-265) | 199 (154-310) | 0.105 | Glucose (mmol/L) | 5.9 (4.8-7.0) | 5.7 (4.7-6.8) | 6.3 (5.2-8.1) | 0.085 | Creatine kinase (U/L) | 67 (49-125) | 69 (54-111) | 63 (47-90) | 0.347 | Creatine kinase–MB (U/L) | 11 (8-17) | 12 (7-18) | 10 (8-13) | 0.255 | PaO2 | 99 (84-136) | 94 (82-113) | 108 (94-147) | 0.117 | PaO2/FiO2 | 473 (365-607) | 466 (344-592) | 495 (393-616) | 0.108 | Coagulation function | | | | | Activated partial thromboplastin time (s) | | | | 0.093 | Prothrombin time (s) | 12.1 (11.6-13.2) | 12.2 (11.7-13.4) | 11.8 (11.5-12.5) | 0.104 | D-dimer(μg/L) | 0.3 (0.2-0.8) | 0.3 (0.2-0.6) | 0.2 (0.1-0.4) | 0.136 | Infection-related biomarkers | | | | | C-reactive protein | 7.8 (3.2-19.9) | 7.7 (3.6-19.8) | 8.0 (4.0-23.5) | 0.079 | Procalcitonin | 0.6 (0.3-1.0) | 0.9 (0.3-1.2) | 0.3 (0.2-0.5) | 0.017 | Erythrocyte sedimentation rate | 14.5 (8.3-26.9) | 13.9 (8.4-22.0) | 15.5 (8.0-37.8) | 0.062 | Coinfection | | | | | Other viruses | 1 (0.56%) | 1 (0.80%) | 0 (0.00%) | 0.106 | Bacteria | 1 (0.56%) | 1 (0.80%) | 0 (0.00%) | 0.106 | Fungi | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | 1.000 |
|
|